12-85989538-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001351288.2(MGAT4C):āc.9A>Cā(p.Lys3Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000168 in 1,603,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001351288.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MGAT4C | NM_001351288.2 | c.9A>C | p.Lys3Asn | missense_variant | 3/5 | ENST00000611864.5 | NP_001338217.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MGAT4C | ENST00000611864.5 | c.9A>C | p.Lys3Asn | missense_variant | 3/5 | 5 | NM_001351288.2 | ENSP00000481096 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152070Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000700 AC: 17AN: 242738Hom.: 0 AF XY: 0.0000533 AC XY: 7AN XY: 131380
GnomAD4 exome AF: 0.0000138 AC: 20AN: 1450900Hom.: 0 Cov.: 30 AF XY: 0.00000832 AC XY: 6AN XY: 721552
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74404
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 02, 2022 | The c.9A>C (p.K3N) alteration is located in exon 5 (coding exon 1) of the MGAT4C gene. This alteration results from a A to C substitution at nucleotide position 9, causing the lysine (K) at amino acid position 3 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at